Summary
We measured serum C-peptide, glucose, pH, islet antibodies and insulin antibody binding at diagnosis in 84 children with Type 1 (insulin-dependent) diabetes. In a subgroup of 33 children, residual insulin secretion (basal and peak C-peptide response to Sustacal), insulin antibody binding and HbA1c were measured at 10 days, 1, 3, 6 and 12 months. At presentation C-peptide correlated positively with age at onset and negatively with the blood glucose concentration. Median C-peptide concentration at diagnosis was low, rose significantly (p<0.05) at 10 days, reached a maximum at 1–3 months and declined gradually to 1 year. C-peptide concentration both at diagnosis and at 10 days correlated with that at 3 and 6 months. Of the factors investigated, only age (p<0.005) and sex (higher in females, p<0.01) were found to have a significant influence on basal/peak C-peptide levels throughout the first year. In particular there was no relationship between C-peptide, HbA1c and insulin dose during this period. A peak C-peptide response at 3–6 months>/<0.32 nmol/l was used to divide the group into two: 16 had a peak response <0.32 nmol/l (low secretors) while in 17, the peak C-peptide was >0.32 nmol/l (high secretors). While the low secretors had significantly (p<0.05) lower C-peptide levels during the first year, there were no differences between low and high secretors in HbA1c or insulin dose. These data suggest that there are two patterns of residual insulin secretion during the first 12 months after diagnosis of Type 1 diabetes. One pattern shows good amplitude and duration of residual insulin secretion, while both these features are significantly (p<0.05) reduced in the other. The C-peptide concentration both at diagnosis and at 10 days, as well as age at onset and sex are important predictors of the pattern to be followed. Our data suggest further that the magnitude of residual insulin secretion does not play a decisive role in metabolic control during this period.
Article PDF
Similar content being viewed by others
References
Baker L, Kaye R, Root AW (1967) The early partial remission of juvenile diabetes rnellitus. The roles of insulin and growth hormone. J Pediatr 71: 825–831
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubinstein AH (1975) Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278–1283
Ludvigsson L, Heding LG, Yarsson Y, Leander E (1977) C-peptide in juvenile diabetics beyond the post-initial remission period. Acta Paediatr Scand 66: 177–184
Hendrikson C, Faber OK, Drejer J, Binder C (1977) Prevalence of residual B-cell function in insulin-treated diabetics evaluated by plasma C-peptide response to intravenous glucagon. Diabetologia 13: 615–619
Gonen B, Goldman J, Baldwin O, Goldberg RB, Ryan WG, Blix PM, Schanzlin D, Fritz KJ, Rubenstein AH (1978) Metabolic control in diabetic patients: Effect of insulin secretory reserve and circulating insulin antibodies. Diabetes 28: 749–753
Binder C, Faber OK (1978) Residual B-cell function and its metabolic consequences. Diabetes 27: 226–229
Ludvigsson J, Heding LG (1978) Beta cell function in childrenwith diabetes. Diabetes 27: 230–234
Madsbad S, Krarup T, Regeur L, Faber OK, Binder C (1980) Insulin secretory reserve in insulin dependent patients at the time of diagnosis and the first 180 days of insulin treatment. Acta Endocrinol 95: 359–363
Block MB, Rosenfield RL, Mako ME, Steiner DF, Rubenstein AH (1973) Sequential changes in B-cell function in insulin treated diabetic patients assessed by C-peptide immunoreactivity. N Engl J Med 288: 1144–1148
Block MB, Mako ME, Steiner DF, Rubenstein AH (1972) Diabetic ketoacidosis: Evidence for C-peptide and proinsulin secretion following recovery. J Clin Endocrinol Metab 35: 402–406
Madsbad S (1983) Prevalence of residual B-cell function and its metabolic consequences in Type I diabetes. Diabetologia 24: 141–147
Rabinowe SL, Eisenbarth GS (1984) Immunotherapy of Type I (insulin-dependent) diabetes mellitus. In: Andreani D, Di Mario U, Federlow KF, Heding LG (eds) Immunology in diabetes. Kimpton, London, pp 171–175
Daneman D, Ehrlich R (1984) Management of insulin-dependent diabetes mellitus in childhood. Med North Am 15: 1852–1859
Clarson C, Daneman D, Drash AL, Becker DJ, Ehrlich RM (1987) Residual B-cell function in children with IDDM: Reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care 10: 33–38
Ellis G, Diamandis EP, Giesbrecht EE, Daneman D, Allen LC (1984) An automated high pressure liguid-chromatographic assay for hemoglobin A1c. Clin Chem 30: 1746–1752
Bonser AM, Webb PG (1983) C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci 19: 297–352
Bottazo GF, Pujol-Borrell R, Doniach D (1981) Humoral and cellular immunity in diabetes mellitus. Clin Immunol Allergy 1: 139–159
Soderstrum WK, Freedman ZR, Lernmark A (1979) Complement dependent cytotoxic islet cell surface antibodies in insulin-dependent diabetes. Diabetes 28: 397
Palmer JP, Demons P, Lyen K, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin dependent diabetics before insulin treatment. Science 222: 1327–1330
Anderson A, Westman J, Hellerström C (1974) Effects of glucose on the ultrastructure and insulin biosynthesis of isolated mouse pancreatic islet maintained in tissue culture. Diabetologia 10: 743–753
Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islet of Langerhans in juvenile diabetes mellitus. Diabetes 27: 251–261
Gepts W, Lecomple PM (1981) The pancreatic islets in diabetes. Am J Med 70: 105–113
Madsbad S, Edsberg B, Saurbrey N, Krarup T, Kühl C (1986) Effect of 1.5 years strict metabolic control on B-cell function in IDDM. Acta Endocrinol 112 (275): 15
Gerbitz K-D, Kemmler W, Edelman A, Summer J, Mehnert H, Wieland OH (1979) Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetes: comparison of C-peptide secretors and now secretors during 24 hours conventional insulin therapy. Eur J Clin Invest 9: 475–483
Dalquist G, Blom L, Bolme P, Hagenfeld L, Ludvigsson F, Persson B, Thalme B, Theorell M, Westin S (1982) Metabolic control in 131 juvenile onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose and one or two insulin injections. Diabetes Care 5: 399–403
Mirel RD, Ginsberg-Fellner F, Horwitz DL, Rayfield EJ (1980) C-peptide reserve in insulin dependent diabetes: comparative responses to glucose, glucagon and tolbutamide. Diabetologia 19: 183–188
Schober E, Schernthaner G, Frisch H, Fink M (1984) B-cell function recovery is not the only factor responsible for remission in Type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase. J Endocrinol Invest 7: 507–512
Gerlis CP, Cartwright B, Owens D (1983) Increases in insulin sensitivity and production cause insulin dose reductions in the first year of Type I diabetes. Diabetes 32: 131A
Yki-Järvinen H, Koivisto VA (1986) Natural course of insulin resistance in Type I diabetes. N Engl J Med 315: 224–230
Ludvigsson J, Heding LG (1976) C-peptide in children with juvenile diabetes. Diabetologia 12: 627–630
Eff C, Faber OK, Deckert T (1978) Persistent insulin secretion assessed by plasma C-peptide estimation in long term juvenile diabetics with low insulin requirement. Diabetologia 15: 169–172
Marner B, Agner T, Binder C, Lernmark A, Nerup J, Paulsen-Mandrup T, Walldorff S (1985) Increased reduction in fasting C- peptide is associated with islet cell antibodies in Type 1 (insulin-dependent) diabetic patients. Diabetologia 28: 875–880
Mustonen A, Knip M, Huttunen N-P, Puukka R, Käär M-L, Åkerblom HK (1984) Evidence of delayed B-cell destruction in Type I (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies. Diabetologia 27: 421–426
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sochett, E.B., Daneman, D., Clarson, C. et al. Factors affecting and patterns of residual insulin secretion during the first year of Type 1 (insulin-dependent) diabetes mellitus in children. Diabetologia 30, 453–459 (1987). https://doi.org/10.1007/BF00279611
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00279611